> Back to JHP Titles

The Prerequisite Importance of Transparency in Judging the Potential Usefulness of Workplace Health Promotion Studies: Beyond ‘Published in a Peer-ReviewED Journal’ and ‘Strength of Study Design Type’

Thomas Wilson, PhD, DrPH,1; Martin MacDowell, MBA, DrPH,2; Gary Montrose 3

1 Founder and Board Chair, Population Health Impact Institute, Loveland, OH

2 Associate Professor, University of Illinois, Rockford, IL

3 Principal, Ashby-Montrose; Co-Founder, Population Health Impact Institute, Loveland, OH

REFERENCES

1. Rosenman MB, Holmes AM, Ackermann RT, Murray MD, Doebbeling CC, Katz B, Li J, Zillich A, Prescott VM, Downs SM, Inui TS. The Indiana Chronic Disease Management Program. Milbank Q. 2006;84(1):135-63.

2. Altman LK. The Doctor’s World: For Science's Gatekeepers, a Credibility Gap. New York Times. May 2, 2006

3. Martinson BC, Anderson MS, de Vries R.. Scientists Behaving Badly. Nature 435, 737-738 (9 June 2005).

4. Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann J. Bias in Cost-Effectiveness Studies: A Systematic Review. BMJ. February 22, 2006.

5. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research JAMA. 2005 Jul 13;294(2):218-28.

6. Aldana SG. Financial Impact of Health Promotion Programs: Comprehensive Review of the Literature. American Journal of Health Promotion. 2001; 15(5): 296-320.

7. Pelletier KR. A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: update VI 2000-2004. J Occup Environ Med. 2005 Oct;47(10):1051-8.

8. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schunemann HJ, Edejer TT, Varonen H, Vist GE, Williams JW Jr, Zaza S; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004 Jun 19;328(7454):1490.

9. Steinberg EP, Eknoyan G, Levin NW, Eschbach JW, Golper TA, Owen WF, Schwab S. Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implications. Am J Kidney Dis. 2000 Jul;36(1):1-11.

10. West S., King V, Carey TS, et al. Systems to Rate the Strength of Scientific Evidence. Evidence Report/Technology Assessment No. 47 (Prepared by the Research Triangle Institute-University of North Carolina Evidence-based Practice Center under Contract No. 290-97-0011). AHRQ Publication No. 02-E016. Rockville, MD Agency for Healthcare Research and Quality. April 2002.

11. Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O’Connell D, Oxman AD, Phillips B, Schuhermann, Tan-Torres Edejer, Tessa, Vist GE, Williams JW Jr and the GRADE working Group. System for Grading the Quality and Strength of the Evidence of recommendations I: Critical Appraisal of Existing Approaches. The GRADE working group. BMC Health Services Research 2004, 4:38;

12. See Health Industry Forum—Scheider Institute for Health Policy, Brandeis University (www.healthforum.brandeis.edu) & Population Health Impact Institute (www.PHIinstitute.org)

13. National Institutes of Health, National Library of Medicine. Publine Medline. See: http://www.nlm.nih.gov/pubs/factsheets/mesh.html

14. Wilson TW, MacDowell M. Framework for Assessing Causality in Disease Management Programs: Principles. Disease Management. 2003, 6: 143-58 & MacDowell M, Wilson T. Framework for Assessing Causality in Disease Management. White Paper for Disease Management Association of America (www.dmaa.org/principlesRobustDMEval.pdf) .

15. Cook DT , Campbell DT. Quasi-Experimental Designs for Research & Analysis Issues for Field Settings. Chicago: Rand McNally, 1979.

16. Angell M. Negative studies. New England Journal of Medicine 1989;321:464-466.

WORK SITE HEALTH PROMOTION ARTICLES INCLUDED IN THIS REVIEW

1. Aldana SG, Merrill RM, Price K, Hardy A, Hager R. Financial impact of a comprehensive multisite workplace health promotion program. Prev Med. 2005 Feb;40(2):131-7.

2. Baggs J, Silverstein B, Foley M. health and safety regulations: Impact of enforcement and consultation on workers' compensation claims rates in Washington State. Am J Ind Med. 2003 May;43(5):483-94.

3. Burton WN, Chen CY, Conti DJ, Schultz AB, Edington DW. The value of the periodic executive health examination: experience at Bank One and summary of the literature. J Occup Environ Med. 2002 Aug;44(8):737-44.

4. Carrivick PJ, Lee AH, Yau KK. Effectiveness of a workplace risk assessment team in reducing the rate, cost, and duration of occupational injury. J Occup Environ Med. 2002 Feb;44(2):155-9.

5. Goine H, Knutsson A, Marklund S, Karlsson B. Sickness absence and early retirement at two workplaces--effects of organisational intervention in Sweden. Soc Sci Med. 2004 Jan;58(1):99-108.

6. Ide R, Mizoue T, Tsukiyama Y, Ikeda M, Yoshimura T. Evaluation of oral health promotion in the workplace: the effects on dental care costs and frequency of dental visits. Community Dent Oral Epidemiol. 2001 Jun;29(3):213-9.

7. Karjalainen K, Malmivaara A, Mutanen P, Pohjolainen T, Roine R, Hurri H. Outcome determinants of subacute low back pain. Spine. 2003 Dec 1;28(23):2634-40.

8. Karjalainen K, Malmivaara A, Mutanen P, Roine R, Hurri H, Pohjolainen T. Mini-intervention for subacute low back pain: two-year follow-up and modifiers of effectiveness. Spine. 2004 May 15;29(10):1069-76.

9. Landstad BJ, Gelin G, Malmquist C, Vinberg S. A statistical human resources costing and accounting model for analysing the economic effects of an intervention at a workplace. Ergonomics. 2002 Sep 15;45(11):764-87.

10. Melhorn JM, Wilkinson L, Riggs JD. Management of musculoskeletal pain in the workplace. J Occup Environ Med. 2001 Feb;43(2):83-93.

11. Schultz AB, Lu C, Barnett TE, Yen LT, McDonald T, Hirschland D, Edington DW. Influence of participation in a worksite health-promotion program on disability days. J Occup Environ Med. 2002 Aug;44(8):776-80

12. Serxner S, Gold D, Anderson D, Williams D. The impact of a worksite health promotion program on short-term disability usage. J Occup Environ Med. 2001 Jan;43(1):25-9.

13. Serxner SA, Gold DB, Grossmeier JJ, Anderson DR. The relationship between health promotion program participation and medical costs: a dose response. J Occup Environ Med. 2003 Nov;45(11):1196-200.

14. Shimizu T, Nagashima S, Mizoue T, Higashi T, Nagata S. A psychosocial-approached health promotion program at a Japanese worksite. J UOEH. 2003 Mar 1;25(1):23-34.

15. Smith JL, Rost KM, Nutting PA, Libby AM, Elliott CE, Pyne JM. Impact of primary care depression intervention on employment and workplace conflict outcomes: is value added? J Ment Health Policy Econ. 2002 Mar;5(1):43-9.

16. Wassell JT, Gardner LI, Landsittel DP, Johnston JJ, Johnston JM. A prospective study of back belts for prevention of back pain and injury. JAMA. 2000 Dec 6;284(21):2727-32.

17. Wickizer TM, Kopjar B, Franklin G, Joesch J. Do drug-free workplace programs prevent occupational injuries? Evidence from Washington State. Health Serv Res. 2004 Feb;39(1):91-110.

18. Wright D, Adams L, Beard MJ, Burton WN, Hirschland D, McDonald T, Napier D, Galante S, Smith T, Edington DW. Comparing excess costs across multiple corporate populations. J Occup Environ Med. 2004 Sep;46(9):937-45.